PROCEPT BioRobotics Corp (PRCT) Social Stream
PROCEPT BIOROBOTICS CORP (PRCT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRCT.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-08 | 4 | $55 | $45 | $50 | $31.48 | 58.83% |
2022-01-12 | 4 | $55 | $45 | $49.5 | $31.48 | 57.24% |
2022-01-24 | 4 | $50 | $25 | $42 | $31.48 | 33.42% |
2022-03-15 | 4 | $50 | $30 | $43.25 | $31.48 | 37.39% |
2022-05-06 | 4 | $50 | $30 | $41.75 | $31.48 | 32.62% |
2022-05-09 | 4 | $50 | $42 | $45.5 | $31.48 | 44.54% |
2022-07-15 | 5 | $53 | $42 | $47.4 | $31.48 | 50.57% |
2022-08-13 | 5 | $53 | $45 | $48.2 | $31.48 | 53.11% |
2022-09-17 | 6 | $53 | $45 | $48.333 | $31.48 | 53.54% |
2022-10-25 | 6 | $58 | $46 | $50.5 | $31.48 | 60.42% |
2022-11-04 | 8 | $60 | $44 | $51.285 | $31.48 | 62.91% |
2022-11-14 | 8 | $60 | $44 | $51.571 | $31.48 | 63.82% |
2023-01-27 | 7 | $60 | $48 | $52.833 | $31.48 | 67.83% |
2023-02-08 | 7 | $60 | $48 | $52.333 | $31.48 | 66.24% |
2023-03-02 | 7 | $60 | $48 | $52.166 | $31.48 | 65.71% |
The Trend in the Analyst Price Target
Over the past 43 weeks, PRCT's average price target has gone up $10.42.
Over the past 43 weeks, PRCT's average upside potential has been 27.74%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-05-09 | 4 | 50 | 42 | 45.500 | 29.23 | 55.66% |
2022-08-05 | 5 | 53 | 45 | 48.200 | 42.04 | 14.65% |
2022-10-25 | 7 | 58 | 46 | 50.500 | 45.65 | 10.62% |
2022-10-25 | 6 | 58 | 46 | 50.500 | 45.65 | 10.62% |
2022-11-14 | 8 | 60 | 48 | 52.833 | 46.44 | 13.77% |
PRCT Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.29 | 6 | 0 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 43 weeks, PRCT's average broker recommendation rating worsened by 0.29.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRCT as an investment opportunity.
- PROCEPT BIOROBOTICS CORP's variance in analysts' estimates is lower than -395.4% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, PROCEPT BIOROBOTICS CORP's number of analysts covering the stock is greater than 514.4% of them.
- In terms of how PROCEPT BIOROBOTICS CORP fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1691.52% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, PROCEPT BIOROBOTICS CORP's upside potential (average analyst target price relative to current price) is greater than 583.17% of them.
Stocks similar to PROCEPT BIOROBOTICS CORP in the Medical Equipment industry regarding analyst recommendations and price targets are FNA, EMBC, and BIOL.
View All Top Stocks by Price Target
Is PRCT a Buy, Hold or Sell? See the POWR Ratings now!